Science
Mechanism of Action
This ingredient functions by activating extracellular signal-regulated kinase (ERK), which subsequently triggers the degradation of microphthalmia-associated transcription factor (MITF). This crucial cascade ultimately leads to a reduction in tyrosinase protein levels, thereby inhibiting the synthesis of melanin.
Research
Clinical Evidence
Medium confidenceN/A
Key findings
- 01 A study demonstrated that N,N,N-trimethyl phytosphingosine-iodide (TMP), when delivered via liposomes, significantly reduced melanin levels in normal human melanocytes. This effect was observed to be dose-dependent.
Transparency
Dusting Analysis
The Formula
Formulation
Safety
Safety Profile
Comprehensive safety assessments by regulatory bodies such as CIR, SCCS, or FDA are not yet available for TRIMETHYL PHYTOSPHINGOSINE IODIDE. It is currently categorized as 'not yet rated' by prominent cosmetic ingredient databases.
Your Skin
Skin Compatibility
Our Assessment
Verdict
TRIMETHYL PHYTOSPHINGOSINE IODIDE shows promising in-vitro efficacy in melanin reduction; however, further clinical and comprehensive safety data are required for a definitive assessment of its broader application.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources